Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Review

Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

       
Total article views   HTML views PDF downloads Totals
8,806 Dovepress* 8,806+ 2,712 11,518
Totals 8,806 2,712 11,518
*Since 13 March 2012
+Since July 2016

View citations on Google Scholar